Cargando…
Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339163/ https://www.ncbi.nlm.nih.gov/pubmed/38013899 http://dx.doi.org/10.1016/j.liver.2022.100116 |
_version_ | 1784760132987518976 |
---|---|
author | Jadaun, Shekhar Singh Jakkilinki, Phani Deepti Hasnain, Ana Tarai, Bansi Dhar Agrawal, Dhiraj Singh, Shweta Agarwal, Shaleen Gupta, Subhash Saigal, Sanjiv |
author_facet | Jadaun, Shekhar Singh Jakkilinki, Phani Deepti Hasnain, Ana Tarai, Bansi Dhar Agrawal, Dhiraj Singh, Shweta Agarwal, Shaleen Gupta, Subhash Saigal, Sanjiv |
author_sort | Jadaun, Shekhar Singh |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9339163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93391632022-08-01 Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients Jadaun, Shekhar Singh Jakkilinki, Phani Deepti Hasnain, Ana Tarai, Bansi Dhar Agrawal, Dhiraj Singh, Shweta Agarwal, Shaleen Gupta, Subhash Saigal, Sanjiv Journal of Liver Transplantation Article The Author(s). Published by Elsevier Masson SAS. 2022 2022-07-31 /pmc/articles/PMC9339163/ /pubmed/38013899 http://dx.doi.org/10.1016/j.liver.2022.100116 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Jadaun, Shekhar Singh Jakkilinki, Phani Deepti Hasnain, Ana Tarai, Bansi Dhar Agrawal, Dhiraj Singh, Shweta Agarwal, Shaleen Gupta, Subhash Saigal, Sanjiv Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients |
title | Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients |
title_full | Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients |
title_fullStr | Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients |
title_full_unstemmed | Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients |
title_short | Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients |
title_sort | efficacy and safety of sars-cov-2 vaccines in living donor liver transplant recipients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339163/ https://www.ncbi.nlm.nih.gov/pubmed/38013899 http://dx.doi.org/10.1016/j.liver.2022.100116 |
work_keys_str_mv | AT jadaunshekharsingh efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT jakkilinkiphanideepti efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT hasnainana efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT taraibansidhar efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT agrawaldhiraj efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT singhshweta efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT agarwalshaleen efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT guptasubhash efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients AT saigalsanjiv efficacyandsafetyofsarscov2vaccinesinlivingdonorlivertransplantrecipients |